Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03143153
Title A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin (CheckMate 648)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

esophageal adenosquamous carcinoma

esophagus squamous cell carcinoma

Therapies

Ipilimumab + Nivolumab

Cisplatin + Fluorouracil

Cisplatin + Fluorouracil + Nivolumab

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | CAN | AUT


No variant requirements are available.